Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102

Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting

Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California , United States , New York , San Diego , Palo Alto , Jaisim Shah , Brian Cooley , Jeffrey Chi , Deyo Weinstein , Decisions Resources Group , Semnur Pharmaceuticals Inc , Practice Research Clinical Rheumatology , Drug Administration , Vickers Vantage Corp , Nasdaq , Scilex Holding Company , Sorrento Therapeutics Inc , Sorrento Company , Corporate Communications , Pivotal Trialc Le Ar Program , Scilex Pharmaceuticals Inc , Company Or Scilex , About Scilex Holding , Holding Company , Sorrento Therapeutics , Corticosteroid Lumbar Epidural Analgesia , Full Text View , Combined Company , Securities Act , Private Securities Litigation Reform Act , Nasdaq Capital Market , Media Contact , Lymphatic Drug , Nicolette Ten , Senior Account Executive , Semnur Pharmaceuticals , Scilex Holding , All Rights , Research Clinical , Chronic Pain , Disease Landscape ,